Drug- or hormone-induced adaptation: Model of adrenergic hypersensitivity

Journal of Pharmacokinetics and Biopharmaceutics

Volumn 17, Issue 3, 1989, Pages 347-364

  Lima, John J ^a   Krukemyer, Julie J ^a   Boudoulas, Harisios ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

receptor; adrenergic stimulation; hypersensitivity; modeling; pharmacodynamics; pharmacokinetics; propranolol

Indexed keywords

BETA ADRENERGIC RECEPTOR; ISOPRENALINE; PROPRANOLOL;

ADULT; CONCENTRATION RESPONSE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHARMACOKINETICS; RECEPTOR UPREGULATION; THEORETICAL STUDY;

ADAPTATION, PHYSIOLOGICAL; ADRENERGIC BETA-ANTAGONISTS; DRUG HYPERSENSITIVITY; HEART RATE; HORMONES; HUMAN; ISOPROTERENOL; KINETICS; MALE; MODELS, BIOLOGICAL; PROPRANOLOL; SUPPORT, NON-U.S. GOV'T; SYMPATHETIC NERVOUS SYSTEM;

EID: 0024442891     PISSN: 0090466X     EISSN: 15738744     Source Type: Journal    
DOI: 10.1007/BF01061901     Document Type: Article

References (33)

1. Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man
2. Kinetics of pharmacologic response
3. Biological basis of drug-induced tolerance, rebound, and dependence. Contribution of recent research on benzodiazepines
4. Molecular mechanisms of receptor desensitization using the μ-adrenergic receptor-coupled adenylate cyclase system as a model
5. Agonist-induced desensitization of the β adrenoreceptor-linked adenylate cyclase
6. Abrupt withdrawal of cardiovascular drugs
7. The β-adrenergic blockade withdrawal phenomenon
8. Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors
9. Decreased beta-adrenergic receptor density on human lymphocytes after chronic treatment with agonists
10. Biphasic adrenergic modulation of β-adrenergic receptor in man
11. Elevation of β-adrenergic receptor density in human lymphocytes after propranolol administration
12. Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects
13. Pharmacodynamics of inotropic and chronotropic responses to oral therapy with propranolol
14. Drug-receptor theory
15. Receptor occupancy and “spare receptors
16. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
17. Changes in the density of β-adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol
18. Effects of pindolol and propranolol on β-adrenergic receptors on human lymphocytes
19. Effects of β-adrenoreceptor antagonist administration on β 2-adrenoreceptor density in human lymphocytes
20. Beta-Adrenoreceptor antagonists (non-selective as well as β1,-selective) with partial agonistic activity decrease β2-adrenoceptor density in human lymphocytes
21. A standardized isoproterenol sensitivity test
22. Plasma catecholamine and hemodynamic responses during isoproterenol infusions in humans
23. Regulation of the heartbeat
24. Biological determinants of propranolol disposition in man
25. Plasma levels of (+) and (−)-propranolol and 4-hydroxy propranolol after administration of racemic propranolol in man
26. Beta-adrenergic blocker withdrawal syndromes in hyper-tension and other cardiovascular diseases
27. Identification of beta-adrenergic receptors in human lymphocytes by (−)-3H-alprenolol binding
28. Human β-adrenoceptors: relation of myocardial and lymphocyte β-adrenoceptor density
29. Correlation between β-adrenergic receptors in human lymphocyte and heart
30. The beta-adrenergic receptor/adenylate cyclase system
31. From epinepherine to cAMP
32. Propranolol withdrawal rebound phenomenon
33. Editorial: Propranolol withdrawal syndrome-Why?